APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastroparesis Drugs

Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.

Selected research

Industry Growth & Trends

Global Gastroparesis Drugs Industry Growth and Trends Forecast to 2032

27 December 202599 pages

Choose your research edition.

Industry ResearchGastroparesis Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastroparesis Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Gastroparesis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastroparesis Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastroparesis Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.

North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.

Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Gastroparesis Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastroparesis Drugs market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastroparesis Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastroparesis Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gastroparesis Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastroparesis Drugs Market by Company

Sumitomo

Cadila Pharmaceuticals

Sanofi

Teva

Johnson & Johnson

Pfizer

Kyowa Kirin Pharmaceuticals

Hanmi Pharm

Ani Pharmaceuticals

Gastroparesis Drugs Segment by Type

Prokinetic Agents

Antiemetic Agents

Others

Gastroparesis Drugs Segment by Application

Diabetic Gastroparesis

Idiopathic Gastroparesis

Gastroparesis Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastroparesis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastroparesis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastroparesis Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastroparesis Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gastroparesis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Prokinetic Agents Table 2. Major Company of Antiemetic Agents Table 3. Major Company of Others Table 4. Global Gastroparesis Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gastroparesis Drugs Sales by Type (2021-2026) & (Kg) Table 6. Global Gastroparesis Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Gastroparesis Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Gastroparesis Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Gastroparesis Drugs Price by Type (2021-2026) & (US$/mg) Table 10. Global Gastroparesis Drugs Sales by Type (2027-2032) & (Kg) Table 11. Global Gastroparesis Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Gastroparesis Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Gastroparesis Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Gastroparesis Drugs Price by Type (2027-2032) & (US$/mg) Table 15. North America Gastroparesis Drugs Sales by Type (2021-2026) & (Kg) Table 16. North America Gastroparesis Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Gastroparesis Drugs Sales by Type (2021-2026) & (Kg) Table 18. Europe Gastroparesis Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Gastroparesis Drugs Sales by Type (2021-2026) & (Kg) Table 20. Asia-Pacific Gastroparesis Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Gastroparesis Drugs Sales by Type (2021-2026) & (Kg) Table 22. Latin America Gastroparesis Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Gastroparesis Drugs Sales by Type (2021-2026) & (Kg) Table 24. Middle East and Africa Gastroparesis Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Gastroparesis Drugs Industry Trends Table 26. Gastroparesis Drugs Industry Drivers Table 27. Gastroparesis Drugs Industry Opportunities and Challenges Table 28. Gastroparesis Drugs Industry Restraints Table 29. Global Gastroparesis Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Gastroparesis Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Gastroparesis Drugs Sales by Company (2021-2026) & (Kg) Table 32. Global Gastroparesis Drugs Sales Share by Company (2021-2026) Table 33. Global Gastroparesis Drugs Market Price by Company (2021-2026) & (US$/mg) Table 34. Global Gastroparesis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Gastroparesis Drugs Major Company Production Sites and Headquarters Table 36. Global Gastroparesis Drugs Company, Product Type & Application Table 37. Global Gastroparesis Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Gastroparesis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Gastroparesis Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Gastroparesis Drugs Sales by Region (2021-2026) & (Kg) Table 42. Global Gastroparesis Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Gastroparesis Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Gastroparesis Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Gastroparesis Drugs Sales (Kg), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 46. Global Gastroparesis Drugs Sales by Region (2027-2032) & (Kg) Table 47. Global Gastroparesis Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Gastroparesis Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Gastroparesis Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Gastroparesis Drugs Sales (Kg), Value (US$ Million), Price (US$/mg) and Gross Margin (2027-2032) Table 51. Global Gastroparesis Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Gastroparesis Drugs Sales by Application (2021-2026) & (Kg) Table 53. Global Gastroparesis Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Gastroparesis Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Gastroparesis Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Gastroparesis Drugs Price by Application (2021-2026) & (US$/mg) Table 57. Global Gastroparesis Drugs Sales by Application (2027-2032) & (Kg) Table 58. Global Gastroparesis Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Gastroparesis Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Gastroparesis Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Gastroparesis Drugs Price by Application (2027-2032) & (US$/mg) Table 62. North America Gastroparesis Drugs Sales by Application (2021-2026) & (Kg) Table 63. North America Gastroparesis Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Gastroparesis Drugs Sales by Application (2021-2026) & (Kg) Table 65. Europe Gastroparesis Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Gastroparesis Drugs Sales by Application (2021-2026) & (Kg) Table 67. Asia-Pacific Gastroparesis Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Gastroparesis Drugs Sales by Application (2021-2026) & (Kg) Table 69. Latin America Gastroparesis Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Gastroparesis Drugs Sales by Application (2021-2026) & (Kg) Table 71. Middle East and Africa Gastroparesis Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Sumitomo Company Information Table 73. Sumitomo Business Overview Table 74. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 75. Sumitomo Gastroparesis Drugs Product Portfolio Table 76. Sumitomo Recent Development Table 77. Cadila Pharmaceuticals Company Information Table 78. Cadila Pharmaceuticals Business Overview Table 79. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 80. Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolio Table 81. Cadila Pharmaceuticals Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 85. Sanofi Gastroparesis Drugs Product Portfolio Table 86. Sanofi Recent Development Table 87. Teva Company Information Table 88. Teva Business Overview Table 89. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 90. Teva Gastroparesis Drugs Product Portfolio Table 91. Teva Recent Development Table 92. Johnson & Johnson Company Information Table 93. Johnson & Johnson Business Overview Table 94. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 95. Johnson & Johnson Gastroparesis Drugs Product Portfolio Table 96. Johnson & Johnson Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 100. Pfizer Gastroparesis Drugs Product Portfolio Table 101. Pfizer Recent Development Table 102. Kyowa Kirin Pharmaceuticals Company Information Table 103. Kyowa Kirin Pharmaceuticals Business Overview Table 104. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 105. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolio Table 106. Kyowa Kirin Pharmaceuticals Recent Development Table 107. Hanmi Pharm Company Information Table 108. Hanmi Pharm Business Overview Table 109. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 110. Hanmi Pharm Gastroparesis Drugs Product Portfolio Table 111. Hanmi Pharm Recent Development Table 112. Ani Pharmaceuticals Company Information Table 113. Ani Pharmaceuticals Business Overview Table 114. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 115. Ani Pharmaceuticals Gastroparesis Drugs Product Portfolio Table 116. Ani Pharmaceuticals Recent Development Table 117. North America Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 118. North America Gastroparesis Drugs Sales by Country (2021-2026) & (Kg) Table 119. North America Gastroparesis Drugs Sales Market Share by Country (2021-2026) Table 120. North America Gastroparesis Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 121. North America Gastroparesis Drugs Sales Market Share Forecast by Country (2027-2032) Table 122. North America Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Gastroparesis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Gastroparesis Drugs Market Share by Country (2021-2026) Table 125. North America Gastroparesis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Gastroparesis Drugs Market Share Forecast by Country (2027-2032) Table 127. Europe Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 128. Europe Gastroparesis Drugs Sales by Country (2021-2026) & (Kg) Table 129. Europe Gastroparesis Drugs Sales Market Share by Country (2021-2026) Table 130. Europe Gastroparesis Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 131. Europe Gastroparesis Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Gastroparesis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Gastroparesis Drugs Market Share by Country (2021-2026) Table 135. Europe Gastroparesis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Gastroparesis Drugs Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Gastroparesis Drugs Sales by Country (2021-2026) & (Kg) Table 139. Asia-Pacific Gastroparesis Drugs Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Gastroparesis Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 141. Asia-Pacific Gastroparesis Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Gastroparesis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Gastroparesis Drugs Market Share by Country (2021-2026) Table 145. Asia-Pacific Gastroparesis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Gastroparesis Drugs Market Share Forecast by Country (2027-2032) Table 147. Latin America Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 148. Latin America Gastroparesis Drugs Sales by Country (2021-2026) & (Kg) Table 149. Latin America Gastroparesis Drugs Sales Market Share by Country (2021-2026) Table 150. Latin America Gastroparesis Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 151. Latin America Gastroparesis Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Gastroparesis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Gastroparesis Drugs Market Share by Country (2021-2026) Table 155. Latin America Gastroparesis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Gastroparesis Drugs Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Gastroparesis Drugs Sales by Country (2021-2026) & (Kg) Table 159. Middle East and Africa Gastroparesis Drugs Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Gastroparesis Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 161. Middle East and Africa Gastroparesis Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Gastroparesis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Gastroparesis Drugs Market Share by Country (2021-2026) Table 165. Middle East and Africa Gastroparesis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Gastroparesis Drugs Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Gastroparesis Drugs Distributors List Table 170. Gastroparesis Drugs Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Gastroparesis Drugs Image Figure 2. Global Gastroparesis Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastroparesis Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastroparesis Drugs Sales (2021-2032) & (Kg) Figure 5. Prokinetic Agents Image Figure 6. Global Prokinetic Agents Sales YoY Growth (2021-2032) & (Kg) Figure 7. Antiemetic Agents Image Figure 8. Global Antiemetic Agents Sales YoY Growth (2021-2032) & (Kg) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 11. Global Gastroparesis Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Gastroparesis Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Gastroparesis Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Gastroparesis Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Gastroparesis Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Gastroparesis Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Gastroparesis Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Gastroparesis Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Gastroparesis Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Gastroparesis Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Gastroparesis Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Gastroparesis Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Gastroparesis Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Diabetic Gastroparesis Image Figure 26. Global Diabetic Gastroparesis Sales YoY Growth (2021-2032) & (Kg) Figure 27. Idiopathic Gastroparesis Image Figure 28. Global Idiopathic Gastroparesis Sales YoY Growth (2021-2032) & (Kg) Figure 29. Global Gastroparesis Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Gastroparesis Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Gastroparesis Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Gastroparesis Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Gastroparesis Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Gastroparesis Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Gastroparesis Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Gastroparesis Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Gastroparesis Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Gastroparesis Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Gastroparesis Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Gastroparesis Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Gastroparesis Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 42. North America Gastroparesis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Gastroparesis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Gastroparesis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Gastroparesis Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 46. Europe Gastroparesis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Gastroparesis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Gastroparesis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Gastroparesis Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. Asia-Pacific Gastroparesis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Gastroparesis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Gastroparesis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Gastroparesis Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Latin America Gastroparesis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Gastroparesis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Gastroparesis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Gastroparesis Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Middle East and Africa Gastroparesis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Gastroparesis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Gastroparesis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Gastroparesis Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Gastroparesis Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Prokinetic Agents
  • Antiemetic Agents
  • Others
Applications
  • Diabetic Gastroparesis
  • Idiopathic Gastroparesis
Companies covered
  • Sumitomo
  • Cadila Pharmaceuticals
  • Sanofi
  • Teva
  • Johnson & Johnson
  • Pfizer
  • Kyowa Kirin Pharmaceuticals
  • Hanmi Pharm
  • Ani Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastroparesis Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gastroparesis Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gastroparesis Drugs Market by Type
  6. 1.3.1 Prokinetic Agents
  7. 1.3.2 Antiemetic Agents
  8. 1.3.3 Others
  9. 1.4 Global Gastroparesis Drugs Market Size by Type
  10. 1.4.1 Global Gastroparesis Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Gastroparesis Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Gastroparesis Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Gastroparesis Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Gastroparesis Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Gastroparesis Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Gastroparesis Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Gastroparesis Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gastroparesis Drugs Industry Trends
  2. 2.2 Gastroparesis Drugs Industry Drivers
  3. 2.3 Gastroparesis Drugs Industry Opportunities and Challenges
  4. 2.4 Gastroparesis Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gastroparesis Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Gastroparesis Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Gastroparesis Drugs Price (2021-2026)
  4. 3.4 Global Gastroparesis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastroparesis Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Gastroparesis Drugs Company, Product Type & Application
  7. 3.7 Global Gastroparesis Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastroparesis Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastroparesis Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastroparesis Drugs Tier 1, Tier 2, and Tier 3
4 Gastroparesis Drugs Regional Status and Outlook
  1. 4.1 Global Gastroparesis Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gastroparesis Drugs Historic Market Size by Region
  3. 4.2.1 Global Gastroparesis Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gastroparesis Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gastroparesis Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gastroparesis Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Gastroparesis Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gastroparesis Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gastroparesis Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gastroparesis Drugs by Application
  1. 5.1 Gastroparesis Drugs Market by Application
  2. 5.1.1 Diabetic Gastroparesis
  3. 5.1.2 Idiopathic Gastroparesis
  4. 5.2 Global Gastroparesis Drugs Market Size by Application
  5. 5.2.1 Global Gastroparesis Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Gastroparesis Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Gastroparesis Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Gastroparesis Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Gastroparesis Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Gastroparesis Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Gastroparesis Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Gastroparesis Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sumitomo
  2. 6.1.1 Sumitomo Company Information
  3. 6.1.2 Sumitomo Business Overview
  4. 6.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sumitomo Gastroparesis Drugs Product Portfolio
  6. 6.1.5 Sumitomo Recent Developments
  7. 6.2 Cadila Pharmaceuticals
  8. 6.2.1 Cadila Pharmaceuticals Company Information
  9. 6.2.2 Cadila Pharmaceuticals Business Overview
  10. 6.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolio
  12. 6.2.5 Cadila Pharmaceuticals Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Gastroparesis Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Gastroparesis Drugs Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Teva
  20. 6.4.1 Teva Company Information
  21. 6.4.2 Teva Business Overview
  22. 6.4.3 Teva Gastroparesis Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva Gastroparesis Drugs Product Portfolio
  24. 6.4.5 Teva Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Gastroparesis Drugs Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Gastroparesis Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Gastroparesis Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Kyowa Kirin Pharmaceuticals
  38. 6.7.1 Kyowa Kirin Pharmaceuticals Company Information
  39. 6.7.2 Kyowa Kirin Pharmaceuticals Business Overview
  40. 6.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolio
  42. 6.7.5 Kyowa Kirin Pharmaceuticals Recent Developments
  43. 6.8 Hanmi Pharm
  44. 6.8.1 Hanmi Pharm Company Information
  45. 6.8.2 Hanmi Pharm Business Overview
  46. 6.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hanmi Pharm Gastroparesis Drugs Product Portfolio
  48. 6.8.5 Hanmi Pharm Recent Developments
  49. 6.9 Ani Pharmaceuticals
  50. 6.9.1 Ani Pharmaceuticals Company Information
  51. 6.9.2 Ani Pharmaceuticals Business Overview
  52. 6.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ani Pharmaceuticals Gastroparesis Drugs Product Portfolio
  54. 6.9.5 Ani Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Gastroparesis Drugs Sales by Country
  2. 7.1.1 North America Gastroparesis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gastroparesis Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Gastroparesis Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gastroparesis Drugs Market Size by Country
  6. 7.2.1 North America Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gastroparesis Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Gastroparesis Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gastroparesis Drugs Sales by Country
  2. 8.1.1 Europe Gastroparesis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gastroparesis Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Gastroparesis Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gastroparesis Drugs Market Size by Country
  6. 8.2.1 Europe Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gastroparesis Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gastroparesis Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gastroparesis Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Gastroparesis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gastroparesis Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gastroparesis Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gastroparesis Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gastroparesis Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gastroparesis Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gastroparesis Drugs Sales by Country
  2. 10.1.1 South America Gastroparesis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gastroparesis Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Gastroparesis Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gastroparesis Drugs Market Size by Country
  6. 10.2.1 South America Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gastroparesis Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Gastroparesis Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gastroparesis Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Gastroparesis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gastroparesis Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gastroparesis Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gastroparesis Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Gastroparesis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gastroparesis Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gastroparesis Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gastroparesis Drugs Value Chain Analysis
  2. 12.1.1 Gastroparesis Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gastroparesis Drugs Production Mode & Process
  7. 12.2 Gastroparesis Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gastroparesis Drugs Distributors
  10. 12.2.3 Gastroparesis Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst